SynthesisBMC cancer2023

Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: a systematic review and meta-analysis of randomized controlled trials.

Danxue Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.